| Market Cap | ₹5.67Cr |
| ROE | 3.71% |
| P/E Ratio(TTM) | -1.13 |
| EPS(TTM) | -2.11 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.69 |
| Book Value | -55.79 |
| Debt to Equity | -1.05 |
| Face Value | 10 |
| Parent Organisation | KOBO Biotech Limited |
| Managing Director | Mr. Ajit Kamath |
| Founded | 1993 |
| BSE Symbol | 531541 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.27 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.05 | ||
| Wockhardt | NA (0.00%) | -449.22 | ||
| Cohance Lifesciences | NA (0.00%) | 65.70 |